Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees
Open accessPublished version of a preprint
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
To the Editor—The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in places where the virus is uncontained poses a global threat from the perspective of public health and vaccine efficacy. Peng et al [1] recently reported on the increased transmissibility with the newly emerged Variant of Concern (VOC) (20C/S:452R and 20C/S:452R) with the L452R mutation in San Francisco. We report the immunological characteristics of a Variant under Investigation (VUI) B.1.617.1, playing a critical role in the current surge of coronavirus disease 2019 (COVID-19) in the western state of Maharashtra, India. Several SARS-CoV-2 variants—B.1.1.7, B.1.351, and B.1.1.28.1—have been reported in India during 2021 [2, 3]. We had sequenced 146 nasopharyngeal/oropharyngeal swabs of COVID-19 cases [4]. Among these, 15 sequences had a combination of L452R and E484Q mutations, which raised concern as both are found in the receptor-binding domain (RBD) of the spike protein. However, the combined effect of these mutations is still unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Starr, T. N., Greaney, A. J., Hilton, S. K., Ellis, D., Crawford, K. H. D., Dingens, A. S., Navarro, M. J., Bowen, J. E., Tortorici, M. A., Walls, A. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.012 · Cited by 1,956
Neutralizing Activity of BNT162b2-Elicited Serum
Liu, Y., Liu, J., Xia, H., Zhang, X., Fontes-Garfias, C. R., Swanson, K. A., Cai, H., Sarkar, R., Chen, W., Cutler, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2102017 · Cited by 537
Ella, R., Vadrevu, K. M., Jogdand, H., Prasad, S., Reddy, S., Sarangi, V., Ganneru, B., Sapkal, G., Yadav, P., Abraham, P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30942-7 · Cited by 424
Self-citationTchesnokova, V., Kulasekara, H., Larson, L., Bowers, V., Rechkina, E., Kisiela, D., Sledneva, Y., Choudhury, D., Maslova, I., Deng, K., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00921-21 · Cited by 217
Tchesnokova, V., Kulakesara, H., Larson, L., et al. (2021) · bioRxiv · doi:10.1101/2021.02.22.432189 · Cited by 154
Teng, S., Sobitan, A., Rhoades, R. E., Liu, D., & Tang, Q. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa233 · Cited by 125
Sapkal, G. N., Yadav, P. D., Ella, R., Deshpande, G. R., Sahay, R. R., Gupta, N., Vadrevu, K. M., Abraham, P., Panda, S., & Bhargava, B. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab051 · Cited by 121
Self-citationFirst isolation of SARS-CoV-2 from clinical samples in India
Sarkale, P., Patil, S., Yadav, P. D., Nyayanit, D. A., Sapkal, G. N., Baradkar, S., Lakra, R., Shete-Aich, A., Prasad, S., Basu, A., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1029_20 · Cited by 112
Self-citationNeutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
Deshpande, G. R., Sapkal, G. N., Tilekar, B. N., Yadav, P. D., Gurav, Y. K., Gaikwad, S., Kaushal, H., Deshpande, K., Kaduskar, O., Sarkale, P., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2382_20 · Cited by 77
Self-citationYadav, P. D., Nyayanit, D. A., Sahay, R. R., Sarkale, P., Pethani, J. D., Patil, S., Baradkar, S., Potdar, V. A., & Patil, D. Y. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab009 · Cited by 45
Self-citation
Research works printed but not linked: 1
- Rambaut, Nat Microbiol
Cited by
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Planas, D., Veyer, D., Baidaliuk, A., Staropoli, I., Guivel-Benhassine, F., Rajah, M. M., Planchais, C., Porrot, F., Robillard, N., Puech, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03777-9 · Cited by 1,992
Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911
Cherian, S., Potdar, V., Jadhav, S., Yadav, P., Gupta, N., Das, M., Rakshit, P., Singh, S., Abraham, P., Panda, S., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9071542 · Cited by 730
Self-citationStructural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
Yuan, M., Huang, D., Lee, C.-C. D., Wu, N. C., Jackson, A. M., Zhu, X., Liu, H., Peng, L., van Gils, M. J., Sanders, R. W., et al. (2021) · doi:10.1101/2021.02.16.430500 · Cited by 364
Ella, R., Reddy, S., Blackwelder, W., Potdar, V., Yadav, P., Sarangi, V., Aileni, V. K., Kanungo, S., Rai, S., Reddy, P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02000-6 · Cited by 344
Self-citationPlanas, D., Veyer, D., Baidaliuk, A., Staropoli, I., Guivel-Benhassine, F., Rajah, M. M., Planchais, C., Porrot, F., Robillard, N., Puech, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.26.445838 · Cited by 266
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
Heitmann, J. S., Bilich, T., Tandler, C., Nelde, A., Maringer, Y., Marconato, M., Reusch, J., Jäger, S., Denk, M., Richter, M., et al. (2022) · Nature · doi:10.1038/s41586-021-04232-5 · Cited by 255
Effectiveness of COVID-19 vaccines against the B.1.617.2 variant
Bernal, J. L., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · doi:10.1101/2021.05.22.21257658 · Cited by 2,888
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Martínez-Flores, D., Zepeda-Cervantes, J., Cruz-Reséndiz, A., Aguirre-Sampieri, S., Sampieri, A., & Vaca, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.701501 · Cited by 240
Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2
Wu, H., Xing, N., Meng, K., Fu, B., Xue, W., Dong, P., Tang, W., Xiao, Y., Liu, G., Luo, H., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.11.005 · Cited by 226
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
Malik, J. A., Ahmed, S., Mir, A., Shinde, M., Bender, O., Alshammari, F., Ansari, M., & Anwar, S. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.12.014 · Cited by 201
SARS-CoV-2 Mutations and their Viral Variants
Cosar, B., Karagulleoglu, Z. Y., Unal, S., Ince, A. T., Uncuoglu, D. B., Tuncer, G., Kilinc, B. R., Ozkan, Y. E., Ozkoc, H. C., Demir, I. N., et al. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.06.001 · Cited by 196
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Lazarevic, I., Pravica, V., Miljanovic, D., & Cupic, M. (2021) · Viruses · doi:10.3390/v13071192 · Cited by 189
Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections
Farinholt, T., Doddapaneni, H., Qin, X., Menon, V., Meng, Q., Metcalf, G., Chao, H., Gingras, M.-C., Avadhanula, V., Farinholt, P., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02103-4 · Cited by 189
COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
Raman, R., Patel, K. J., & Ranjan, K. (2021) · Biomolecules · doi:10.3390/biom11070993 · Cited by 188
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Rajah, M. M., Hubert, M., Bishop, E., Saunders, N., Robinot, R., Grzelak, L., Planas, D., Dufloo, J., Gellenoncourt, S., Bongers, A., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108944 · Cited by 188
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Ramesh, S., Govindarajulu, M., Parise, R. S., Neel, L. T., Shankar, T., Patel, S., Lowery, P., Smith, F., Dhanasekaran, M., & Moore, T. (2021) · Vaccines · doi:10.3390/vaccines9101195 · Cited by 176
Coronavirus variants are spreading in India — what scientists know so far
Vaidyanathan, G. (2021) · Nature · doi:10.1038/d41586-021-01274-7 · Cited by 164
SARS‐CoV‐2 variants and vulnerability at the global level
Chavda, V. P., Patel, A., & Vaghasiya, D. D. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27717 · Cited by 145
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
Thye, A. Y.-K., Law, J. W., Pusparajah, P., Letchumanan, V., Chan, K., & Lee, L. (2021) · Biomedicines · doi:10.3390/biomedicines9101303 · Cited by 133
Rahman, M. M., Masum, M. H. U., Wajed, S., & Talukder, A. (2022) · VirusDisease · doi:10.1007/s13337-022-00755-1 · Cited by 127
Chakraborty, C., Bhattacharya, M., & Sharma, A. R. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2270 · Cited by 111
Yadav, P. D., Sapkal, G. N., Ella, R., Sahay, R. R., Nyayanit, D. A., Patil, D. Y., Deshpande, G. R., Shete, A. M., Gupta, N., Mohan, V., et al. (2021) · Journal of Travel Medicine · doi:10.1093/jtm/taab104 · Cited by 108
Self-citationAn update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
Hillary, V. E., & Ceasar, S. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13952 · Cited by 130
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
Abulsoud, A. I., El‐Husseiny, H. M., El-Husseiny, A. A., El‐Mahdy, H. A., Ismail, A., Elkhawaga, S. Y., Khidr, E. G., Fathi, D., Mady, E. A., Najda, A., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113977 · Cited by 116
Teruel, N., Mailhot, O., & Najmanovich, R. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009286 · Cited by 105
The real-life impact of vaccination on COVID-19 mortality in Europe and Israel
Jabłońska, K., Aballéa, S., & Toumi, M. (2021) · Public Health · doi:10.1016/j.puhe.2021.07.037 · Cited by 116
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Dhawan, M. K., Sharma, A., Choudhary, P., Thakur, N., Rajkhowa, T. K., & Choudhary, O. P. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2068883 · Cited by 127
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
Akkız, H. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.849217 · Cited by 113
COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions
Khan, W. H., Hashmi, Z., Goel, A., Ahmad, R., Gupta, K., Khan, N., Alam, I., Ahmed, F., & Ansari, M. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.690621 · Cited by 115
Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies
Alenquer, M., Ferreira, F., Lousa, D., Valério, M., Medina-Lopes, M., Bergman, M., Gonçalves, J., Demengeot, J., Leite, R. B., Lilue, J., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009772 · Cited by 107
Kumar, V., Singh, J., Hasnain, S. E., & Sundar, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179131 · Cited by 97
Mlcochova, P., Kemp, S., Dhar, M. S., Papa, G., Meng, B., Mishra, S., Whittaker, C., Mellan, T., Ferreira, I., Datir, R., et al. (2021) · doi:10.1101/2021.05.08.443253 · Cited by 90
Wang, Y., Xu, C., Wang, Y., Qin, H., Zhang, C., Li, Z., Xu, S., Zuo, Q., Liu, C., Huang, Z. W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27350-0 · Cited by 87
Halawa, S., Pullamsetti, S. S., Bangham, C. R. M., Stenmark, K. R., Dorfmüller, P., Frid, M. G., BUTROUS, G. S., Morrell, N. W., Pérez, V. D. J., Stuart, D. I., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00640-2 · Cited by 90
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Dubey, A., Choudhary, S., Kumar, P., & Tomar, S. (2021) · Current Microbiology · doi:10.1007/s00284-021-02724-1 · Cited by 85
Advances in the design and development of SARS-CoV-2 vaccines
Peng, X., Cheng, J., Gong, H., Yuan, M.-D., Zhao, X., Li, Z., & Wei, D. (2021) · Military Medical Research · doi:10.1186/s40779-021-00360-1 · Cited by 91
miRNAs as cornerstones in adipogenesis and obesity
Elkhawaga, S. Y., Ismail, A., Elsakka, E. G. E., Doghish, A. S., Elkady, M. A., & El‐Mahdy, H. A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121382 · Cited by 81
Ella, R., Reddy, S., Blackwelder, W., Potdar, V., Yadav, P., Sarangi, V., Aileni, V. K., Kanungo, S., Rai, S., Reddy, P., et al. (2021) · medRxiv · doi:10.1101/2021.06.30.21259439 · Cited by 77
Self-citationSARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
Khan, A., Khan, T., Ali, S., Aftab, S., Wang, Y., Wang, Q., Khan, M., Suleman, M., Ali, S., Heng, W., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112176 · Cited by 78
Cerutti, G., Guo, Y., Wang, P., Nair, M. S., Wang, M., Huang, Y., Yu, J., Liu, L., Katsamba, P. S., Bahna, F., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109928 · Cited by 72
COVID-19 vaccines: concerns beyond protective efficacy and safety
Lai, C., Chen, I., Chao, C., Lee, P., Ko, W., & Hsueh, P. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1949293 · Cited by 72
Nucleic Acid Testing of SARS-CoV-2
Yoo, H. M., Kim, I.-H., & Kim, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116150 · Cited by 76
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker
Chen, Y., Zhang, Y., Yan, R., Wang, G., Zhang, Y., Zhang, Z., Li, Y., Ou, J., Chu, W., Liang, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00740-y · Cited by 70
SARS-CoV-2 variants and effectiveness of vaccines: a review of current evidence
Tatsi, E., Filippatos, F., & Michos, A. G. (2021) · Epidemiology and Infection · doi:10.1017/s0950268821002430 · Cited by 77
Cantón, R., Ramos, P. D. L., Botella, A. G., García‐Lledó, A., Gómez‐Pavón, J., del Castillo, J. M. G., Hernández‐Sampelayo, T., Delgado, M. C. M., Martín‐Sánchez, F. J., Martínez‐Sellés, M., et al. (2021) · Revista Española de Quimioterapia · doi:10.37201/req/071.2021 · Cited by 74
Jacobson, K. B., Pinsky, B. A., Montez Rath, M. E., Wang, H., Miller, J. A., Skhiri, M., Shepard, J., Mathew, R., Lee, G., Bohman, B., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab554 · Cited by 62
Antigenic characterization of influenza and SARS-CoV-2 viruses
Wang, Y., Tang, C. Y., & Wan, X. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03806-6 · Cited by 70
The ins and outs of SARS-CoV-2 variants of concern (VOCs)
Salehi-Vaziri, ., Fazlalipour, M., Khorrami, S. M. S., Azadmanesh, K., Pouriayevali, M. H., Jalali, T., Shoja, Z., & Maleki, A. (2022) · Archives of Virology · doi:10.1007/s00705-022-05365-2 · Cited by 67
Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
Lou, F., Li, M., Pang, Z., Jiang, L., Guan, L., Tian, L., Hu, J., Fan, J., & Fan, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.744242 · Cited by 58
Emerging SARS-CoV-2 Variants Can Potentially Break Set Epidemiological Barriers in COVID-19
Kumar, A., Parashar, R., Kumar, S., Faiq, M. A., Kumari, C., Kulandhasamy, M., Narayan, R. K., Jha, R. K., Singh, H. N., Prasoon, P., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27467 · Cited by 55
Will the COVID-19 pandemic end with the Delta and Omicron variants?
Wang, C., & Han, J. (2022) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01369-7 · Cited by 54
Neutralization Potential of Covishield Vaccinated Individuals Sera Against B.1.617.1
Yadav, P. D., Sapkal, G. N., Abraham, P., Deshpande, G., Nyayanit, D. A., Patil, D. Y., Gupta, N., Sahay, R. R., Shete, A. M., Kumar, S., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab483 · Cited by 51
Self-citationGenetic emergence of B.1.617.2 in COVID-19
Kirola, L. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100929 · Cited by 58
SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variantPreprint
Yadav, P., Mohandas, S., Shete, A., Nyayanit, D. A., Gupta, N., Patil, D., Sapkal, G., Potdar, V., Kadam, M., Kumar, A., et al. (2021) · bioRxiv · doi:10.1101/2021.05.05.442760 · Cited by 51
Self-citationThe challenges of COVID‐19 Delta variant: Prevention and vaccine development
He, X., He, C., Hong, W., Zhang, K., & Wei, X. (2021) · MedComm · doi:10.1002/mco2.95 · Cited by 54
Chen, L., Lu, L., Choi, C. Y.-K., Cai, J., Tsoi, H., Chu, A. W., Ip, J. D., Chan, W.-M., Zhang, R., Zhang, X., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab656 · Cited by 52
Tragni, V., Preziusi, F., Laera, L., Onofrio, A., Mercurio, I., Todisco, S., Volpicella, M., Grassi, A., & Pierri, C. L. (2022) · The EPMA Journal · doi:10.1007/s13167-021-00267-w · Cited by 52
Bhattacharya, M., Chatterjee, S., Sharma, A. R., Lee, S., & Chakraborty, C. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-01001-3 · Cited by 55
Dharmadhikari, T., Rajput, V., Yadav, R., Boargaonkar, R., Patil, D., Kale, S., Kamble, S. P., Dastager, S. G., & Dharne, M. S. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151038 · Cited by 46
Self-citationSARS-CoV-2 journey: from alpha variant to omicron and its sub-variants
Hattab, D., Amer, M. F. A., Al‐Alami, Z. M., & Bakhtiar, A. (2024) · Infection · doi:10.1007/s15010-024-02223-y · Cited by 51
Peng, L., Hu, Y., Mankowski, M. C., Ren, P., Chen, R. E., Wei, J., Zhao, M., Li, T., Tripler, T. N., Ye, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29288-3 · Cited by 43
Pseudoscience and fraudulent products for COVID-19 management
Chavda, V. P., Sonak, S. S., Munshi, N. K., & Dhamade, P. N. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-21967-4 · Cited by 50
Vadrevu, K. M., Ganneru, B., Reddy, S., Jogdand, H., Raju, D., Praturi, U., Sapkal, G. N., Yadav, P. D., Reddy, P., Verma, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-16097-3 · Cited by 40
Self-citationPostvaccination SARS‐CoV‐2 infection among healthcare workers: A systematic review and meta‐analysis
Chandan, S., Khan, S. R., Deliwala, S. S., Mohan, B. P., Ramai, D., Chandan, O. C., & Facciorusso, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27457 · Cited by 41
Malladi, S. K., Patel, U. R., Rajmani, R. S., Singh, R., Pandey, S., Kumar, S., Khaleeq, S., van Vuren, P. J., Riddell, S., Goldie, S., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00276 · Cited by 40
Changrob, S., Fu, Y., Guthmiller, J. J., Halfmann, P., Li, L., Stamper, C. T., Dugan, H. L., Accola, M., Rehrauer, W., Zheng, N.-Y., et al. (2021) · mBio · doi:10.1128/mbio.02975-21 · Cited by 41
Ubah, O. C., Lake, E. W., Gunaratne, G. S., Gallant, J. P., Fernie, M., Robertson, A. J., Marchant, J. S., Bold, T. D., Langlois, R. A., Matchett, W. E., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27611-y · Cited by 40
Yadav, P. D., Sapkal, G. N., Ella, R., Sahay, R. R., Nyayanit, D. A., Patil, D. Y., Deshpande, G. R., Shete, A. M., Gupta, N., Mohan, V., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.05.447177 · Cited by 39
Self-citationShu, Y., He, J., Pei, R., He, P., Huang, Z., Chen, S., Ou, Z., Deng, J., Zeng, P.-Y., Zhou, J., et al. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001702 · Cited by 39
Zhang, Z., Zhang, J., & Wang, J. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.952916 · Cited by 41
The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City
Cedro‐Tanda, A., Gómez-Romero, L., Alcaraz, N., de Anda‐Jáuregui, G., Peñaloza, F., Moreno, B., Escobar-Arrazola, M. A., Ramirez-Vega, O. A., Munguía-Garza, P., Garcia-Cardenas, F., et al. (2021) · Viruses · doi:10.3390/v13112182 · Cited by 35
Negi, S. S., Schein, C. H., & Braun, W. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-04950-4 · Cited by 36
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
Tulimilli, S. V., Dallavalasa, S., Basavaraju, C. G., Rao, V. K., Chikkahonnaiah, P., Madhunapantula, S. V., & Veeranna, R. P. (2022) · Vaccines · doi:10.3390/vaccines10101751 · Cited by 43
Focosi, D., Tuccori, M., Baj, A., & Maggi, F. (2021) · Viruses · doi:10.3390/v13071211 · Cited by 40
SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies
Mlčochová, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Mishra, S., Whittaker, C., Mellan, T. A., Ferreira, I. A. T. M., Datir, R. P., et al. (2021) · Greater South Information System · doi:10.60692/dy28a-h7650 · Cited by 61
A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice
Cao, K., Wang, X., Peng, H., Ding, L., Wang, X., Hu, Y., Dong, L., Yang, T., Hong, X., Xing, M., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01578-21 · Cited by 40
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
Wang, P., Zhou, R., Zhou, R., Li, W., Weerasinghe, J., Chen, S., Rehm, B. H. A., Zhao, L., Frentiu, F. D., Zhang, Z., et al. (2022) · Theranostics · doi:10.7150/thno.70098 · Cited by 39
Bayarri‐Olmos, R., Johnsen, L. B., Idorn, M., Reinert, L. S., Rosbjerg, A., Vang, S., Hansen, C. B., Helgstrand, C., Bjelke, J. R., Bak-Thomsen, T., et al. (2021) · eLife · doi:10.7554/elife.70002 · Cited by 35
D’Aoust, P. M., Tian, X., Towhid, S. T., Xiao, A., Mercier, É., Hegazy, N., Jia, J., Wan, S., Kabir, M. P., Fang, W., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.158547 · Cited by 43
Chadha, J., Khullar, L., & Mittal, N. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15687 · Cited by 38
Olsen, R. J., Christensen, P. A., Long, S. W., Subedi, S., Hodjat, P., Olson, R., Nguyen, M., Davis, J. J., Yerramilli, P., Saavedra, M. O., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.002 · Cited by 31
Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers
Yadav, P. D., Sarkale, P., Razdan, A., Gupta, N., Nyayanit, D. A., Sahay, R. R., Potdar, V. A., Patil, D. Y., Baradkar, S., Kumar, A., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.12.011 · Cited by 31
Self-citationNeutralizing antibody: a savior in the Covid-19 disease
Gupta, S. L., & Jaiswal, R. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07020-6 · Cited by 31
Basheer, A., & Zahoor, I. (2021) · Microorganisms · doi:10.3390/microorganisms9122609 · Cited by 30
Genetic drift in the genome of SARS COV‐2 and its global health concern
Bano, I., Sharif, M., & Alam, S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27337 · Cited by 28
A review of the safety and efficacy of current COVID-19 vaccines
Huang, Z., Su, Y., Zhang, T., & Xia, N. (2022) · Frontiers of Medicine · doi:10.1007/s11684-021-0893-y · Cited by 32
A survey on computational methods in discovering protein inhibitors of SARS-CoV-2
Liu, Q., Wan, J., & Wang, G. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab416 · Cited by 26
Singh, S., Sharma, A. K., Gupta, A. K., Joshi, M. A., Aggarwal, A., Soni, N., Sana, Jain, D. K., Verma, P., Khandelwal, D., et al. (2022) · Lung India · doi:10.4103/lungindia.lungindia_265_22 · Cited by 27
Rabaan, A. A., Al-Ahmed, S. H., Albayat, H., Alwarthan, S. M., Alhajri, M. M., Najim, M. A., Alshehail, B. M., Al-Adsani, W., Alghadeer, A., Abduljabbar, W. A., et al. (2023) · Medicina · doi:10.3390/medicina59030507 · Cited by 29
Pasquale, A. D., Radomski, N., Mangone, I., Calistri, P., Lorusso, A., & Cammà, C. (2021) · BMC Genomics · doi:10.1186/s12864-021-08112-0 · Cited by 28
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Haddad, F., Dokmak, G., & Karaman, R. (2022) · Life · doi:10.3390/life12111758 · Cited by 27
Impact of COVID-19 Vaccination: A Global Perspective
Singh, P., Anand, A., Rana, S., Kumar, A., Goel, P., Kumar, S., Gouda, K. C., & Singh, H. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1272961 · Cited by 25
Peng, L., Renauer, P. A., Ökten, A., Fang, Z., Park, J. J., Zhou, X., Lin, Q., Dong, M. B., Filler, R., Xiong, Q., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100634 · Cited by 21
An overview of the ongoing challenges in SARS-CoV-2 global control
Shehata, A. A., Parvin, R., Nagy, A., Wang, Y., Azhar, T. M., Attia, Y. A., Azhar, E. I., Paul, A. K., & Rahmatullah, M. (2021) · German Journal of Microbiology · doi:10.51585/gjm.2021.2.0006 · Cited by 24
Beeraka, N. M., Sukocheva, O. A., Lukina, E., Liu, J., & Fan, R. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2346 · Cited by 23
Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants
Li, C., Guo, Y., Fang, Z., Zhang, H., Zhang, Y., & Chen, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.804945 · Cited by 25
Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development
He, X., He, C., Hong, W., Yang, H. J., & Wei, X. (2023) · Medicinal Research Reviews · doi:10.1002/med.21941 · Cited by 28
Singh, P., Sharma, K. K., Singh, P., Bhargava, A., Negi, S. S., Sharma, P., Bhise, M. P., Tripathi, M. K., Jindal, A., & Nagarkar, N. M. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105404 · Cited by 23
Metadata
- Authors
- Yadav, P. D., Sapkal, G. N., Abraham, P., Ella, R., Deshpande, G., Patil, D. Y., Nyayanit, D. A., Gupta, N., Sahay, R. R., Shete, A. M., Panda, S., Bhargava, B., & Mohan, V. K.
- Affiliations
- ICMR-National Institute of Virology (IN)
- Bharat Biotech (India) (IN)
- Indian Council of Medical Research (IN)
- Corresponding author
- Yadav, Pragya D
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-07
- Volume
- 74
- Issue
- 2
- Pages
- 366-368
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3159365602
- Cited by
- 251
- References
- 14
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 10 · 2023: 26 · 2022: 76 · 2021: 133
- FWCI
- 19.38
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Clinical Infectious Diseases (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Indian Council of Medical Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Keywords
- SARS-CoV-2, Omicron variant, L452R mutation, receptor binding domain, Maharashtra, COVID-19 pandemic, spike protein mutations
- MeSH terms
- Antibodies, Viral, Humans, Neutralization Tests, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.